Idiopathic Pulmonary Fibrosis - from Epidemiology to Gene Mapping
نویسنده
چکیده
.......................................................................................................................................9 INTRODUCTION............................................................................................................................11 REVIEW OF THE LITERATURE................................................................................................13 1. Idiopathic pulmonary fibrosis.................................................................................................13 1.1 From history to novel classification.....................................................................................13 1.2 Epidemiology.......................................................................................................................14 1.3 Etiology................................................................................................................................15 1.4 Pathological findings............................................................................................................16 1.5 Diagnosis of idiopathic pulmonary fibrosis .........................................................................19 1.6 Treatment .............................................................................................................................21 2. Gene mapping of complex diseases ........................................................................................23 2.1 General .................................................................................................................................23 2.2 Linkage analysis...................................................................................................................24 2.3 Association analysis.............................................................................................................27 2.4 Characteristics of the Finnish population.............................................................................28 3. Genetics of idiopathic pulmonary fibrosis .............................................................................31 3.1 Idiopathic pulmonary fibrosis in families ............................................................................31 3.2 Candidate genes ...................................................................................................................32 3.2.1 Immune response genes ................................................................................................32 3.2.2 Genes in biochemical defence.......................................................................................34 3.3 Mouse models ......................................................................................................................36 AIMS OF THE STUDY...................................................................................................................39 MATERIALS AND METHODS ....................................................................................................40 1. Patient selection........................................................................................................................40 1.1 Identifying idiopathic pulmonary fibrosis patients ..............................................................40 1.2 Family selection for the genome-wide scan and for haplotype association analysis...........40 1.3 Replication data set ..............................................................................................................41 1.4 Patients and controls for association studies on the CR1 and ESCOD genes......................41 2. Diagnostic criteria ....................................................................................................................42 3. Genome scan and fine mapping markers and genotyping methods....................................42 4. Genotyping of the Pro1827Arg variant in the CR1 gene .....................................................43 5. Genotyping of the Arg213Gly variant in the ECSOD gene .................................................44 6. Sequencing ................................................................................................................................44 7. mRNA expression.....................................................................................................................45 8. In vitro translation ...................................................................................................................46 9. In situ hybridization.................................................................................................................47 10. Statistical analyses .................................................................................................................47 10.1 Linkage analysis.................................................................................................................47 10.2 Power estimations for linkage analysis (simulations)........................................................47 10.3 Association analyses ..........................................................................................................48 RESULTS .........................................................................................................................................49 1. Prevalence .................................................................................................................................49 2. Familial idiopathic pulmonary fibrosis..................................................................................50 3. Genome-wide linkage analysis ................................................................................................51 4. Haplotype association analysis on chromosomes 3, 4, 9, 12, and 13....................................53 5. Positional candidate genes.......................................................................................................54 6. Sequencing ................................................................................................................................55 7. Association study on the Pro1827Arg variant in the CR1 gene...........................................56 8. Association study on the Arg213Gly variant in the ESCOD gene.......................................56 DISCUSSION ...................................................................................................................................57 1. Prevalence of idiopathic pulmonary fibrosis .........................................................................57 2. Familial idiopathic pulmonary fibrosis..................................................................................58 3. Identifying novel candidate genomic region for idiopathic pulmonary fibrosis by genome-wide scan combined with hierarchial association study ............................................59 4. Characterization of candidate genes ......................................................................................61 5. Association studies on functional candidate genes CR1 and ECSOD.................................63 CONCLUSIONS ..............................................................................................................................66 ACKNOWLEDGEMENTS.............................................................................................................67 REFERENCES.................................................................................................................................69 ORIGINAL COMMUNICATIONS ...............................................................................................82
منابع مشابه
Epstein-Barr Virus and Human Herpesvirus 8 in Idiopathic Pulmonary Fibrosis
Background & Objective: Idiopathic pulmonary fibrosis (IPF) is a chronic and uniformly fatal interstitial lung disease with incompletely understood pathogenesis. Several studies have given the evidence for and against viral cofactors in the pathogenesis of Idiopathic pulmonary fibrosis. In this study Epstein-Bar Virus (EBV) and Human Herpesvirus 8 (HH...
متن کاملREPORT OF FOUR CASES OF FAMILIAL IDIOPATHIC PULMONARY FIBROSIS
A 25 year old male and his 46 year old aunt presented with shortness of breath and a dramatic response to steroids. The other two patients are sisters with more advanced disease. One of these responded partially to steroids, while the other died within 4 months of treatment. The genetic basis and pathogenesis are discussed.
متن کاملPulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Chance for a Multidisciplinary Treatment Approach
Background and Objectives: Idiopathic pulmonary fibrosis (IPF) is characterized by progressively worsening lung function, ventilation capacity, dyspnea, and finally reduced exercise intolerance. All of these have a significant negative impact on functional capacity and quality of life. In this study, we aim to evaluate the effects of pulmonary rehabilitation (PR) in IPF and assess the predictor...
متن کاملPediatric Idiopathic Pulmonary Fibrosis: A Case Series report
Khalilzadeh S1, Baghaei N2, Bolorsaz MR1, Masjedi MR3 1. Associate professor, Department of pediatrics, Education, research and treatment center of tuberculosis and long diseases, Shahid Beheshti University of medical sciences 2. Assistant professor, Department of pediatrics, Education, research and treatment center of tuberculosis and long diseases, Shahid Beheshti University of medical s...
متن کاملIdiopathic pulmonary fibrosis: diagnosis and epidemiology.
In 2000, the American Thoracic Society and European Respiratory Society published the first consensus statement providing guidelines on the diagnosis and treatment of idiopathic pulmonary fibrosis (IPF). This statement presented, for the first time, diagnostic criteria for IPF and recommendations for treatment. Results from several studies have reshaped the thinking on IPF, and as a result, the...
متن کامل